デフォルト表紙
市場調査レポート
商品コード
1265648

ニュートリゲノミクスの世界市場

Nutrigenomics

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 89 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
ニュートリゲノミクスの世界市場
出版日: 2023年04月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 89 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

ニュートリゲノミクスの世界市場は2030年に25億米ドルに達する

COVID-19後の変化したビジネス環境において、2022年に7億1,500万米ドルと推定されるニュートリゲノミクスの世界市場は、2022年から2030年にかけてCAGR17%で成長し、2030年には25億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである試薬・キットは、CAGR18.1%で成長し、分析期間終了時には18億米ドルに達すると予測されます。パンデミック後の回復を考慮し、サービス分野の成長は、今後8年間のCAGRが14.7%に修正される見込みです。

米国市場は2億920万米ドル、中国はCAGR16%の成長を予測

米国のニュートリゲノミクス市場は、2022年に2億920万米ドルと推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてのCAGRが16%となり、2030年には4億2,190万米ドルの市場規模に達すると予測されます。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ14.7%と13.8%の成長が予測されています。欧州では、ドイツがCAGR10.8%で成長すると予測されています。

調査対象企業の例

  • BASF SE
  • Cell-Logic
  • Cura Integrative Medicine
  • Geneus Health, LLC
  • Genova Diagnostics
  • GX Sciences, Inc.
  • Koninklijke DSM N.V.
  • Metagenics, Inc.
  • Nutrigenomix
  • NutriProCan
  • Orig3n
  • Prenetics Limited
  • Seven Oaks General Hospital, part of Winnipeg Regional Health Authority
  • The Gene Box
  • Unilever
  • Xcode Life

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP22397

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Nutrigenomics Market to Reach $2.5 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Nutrigenomics estimated at US$715 Million in the year 2022, is projected to reach a revised size of US$2.5 Billion by 2030, growing at aCAGR of 17% over the period 2022-2030. Reagents & Kits, one of the segments analyzed in the report, is projected to record 18.1% CAGR and reach US$1.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Services segment is readjusted to a revised 14.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $209.2 Million, While China is Forecast to Grow at 16% CAGR

The Nutrigenomics market in the U.S. is estimated at US$209.2 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$421.9 Million by the year 2030 trailing a CAGR of 16% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.7% and 13.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.8% CAGR.

Select Competitors (Total 33 Featured) -

  • BASF SE
  • Cell-Logic
  • Cura Integrative Medicine
  • Geneus Health, LLC
  • Genova Diagnostics
  • GX Sciences, Inc.
  • Koninklijke DSM N.V.
  • Metagenics, Inc.
  • Nutrigenomix
  • NutriProCan
  • Orig3n
  • Prenetics Limited
  • Seven Oaks General Hospital, part of Winnipeg Regional Health Authority
  • The Gene Box
  • Unilever
  • Xcode Life

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Nutrigenomics - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Nutrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Nutrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Nutrigenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Obesity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Cancer Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Nutrigenomics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • JAPAN
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • CHINA
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: China 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: China 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • EUROPE
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Nutrigenomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Nutrigenomics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • FRANCE
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: France 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: France 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • GERMANY
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2023 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2023 & 2030

IV. COMPETITION